Bradley Kendall

Professor Kendall’s work on the role of obesity in gastrointestinal cancer has been acknowledged nationally and internationally. His work has a strong translational focus contributing to the development of clinical risk prediction tools, national clinical guidelines, and position statements. As an early career researcher, he has been a chief investigator on research grants at national, state and institutional level including funding from the Cancer Australia, Queensland Cancer Fund, Translational Research Institute, Princess Alexandra Research Foundation and the Gallipoli Research Foundation. He has been an associate investigator on national and state grants worth $4.5 million from the NHMRC, Cancer Australia and the Cancer Council of New South Wales. He has been involved in international and national collaborations including the NCI supported International Barrett’s and esophageal adenocarcinoma Consortium (BEACON) and the NHMRC supported Progression of Barrett’s Esophagus to Cancer network (PROBE-NET). Professor Kendall was a member of the Cancer Council of Australia working group that developed, in collaboration with community stakeholders, clinical practice guidelines for the management of Barrett’s oesophagus and early oesophageal adenocarcinoma. Professor Kendall has been widely involved in professional organizations both at a national and state level including the Gastroenterology Society of Australia.